TMO
Thermo Fisher Scientific Inc. (NYSE: TMO) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $256.6B. Its Maz Rating is 3.95 out of 5 (B+, Buy), ranked against the other companies in its sector.
Factor scores: Valuation 1.38, Growth 3.03, Profitability 4.81, Financial Health 2.77, Momentum 4.28 (as of 2026-10-16).